These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 9824868

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Treatment of oedematous, proliferative and neovascular diseases by intravitreal triamcinolone acetonide].
    Jonas JB, Kreissig I, Degenring RF.
    Klin Monbl Augenheilkd; 2003 Jun; 220(6):384-90. PubMed ID: 12830391
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection.
    Sakalar YB, Unlu K, Keklikci U, Caca I, Senol BB.
    Ann Ophthalmol (Skokie); 2008 Jun; 40(3-4):190-2. PubMed ID: 19230363
    [Abstract] [Full Text] [Related]

  • 28. Cataract progression after intravitreal triamcinolone injection.
    Cekiç O, Chang S, Tseng JJ, Akar Y, Barile GR, Schiff WM.
    Am J Ophthalmol; 2005 Jun; 139(6):993-8. PubMed ID: 15953428
    [Abstract] [Full Text] [Related]

  • 29. Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection.
    Pizzimenti JJ, Nickerson MM, Pizzimenti CE, Kasten-Aker AG.
    Optom Vis Sci; 2006 Jul; 83(7):421-5. PubMed ID: 16840867
    [Abstract] [Full Text] [Related]

  • 30. Evaluation of the toxicity of subretinal triamcinolone acetonide in the rabbit.
    Kozak I, Cheng L, Mendez T, Davidson MC, Freeman WR.
    Retina; 2006 Sep; 26(7):811-7. PubMed ID: 16963856
    [Abstract] [Full Text] [Related]

  • 31. Intravitreal triamcinolone acetonide in patients with macular oedema due to central retinal vein occlusion.
    Krepler K, Ergun E, Sacu S, Richter-Müksch S, Wagner J, Stur M, Wedrich A.
    Acta Ophthalmol Scand; 2005 Feb; 83(1):71-5. PubMed ID: 15715561
    [Abstract] [Full Text] [Related]

  • 32. One year of intravitreal injections of steroids.
    Deckers V, Priem H, Verbraeken H.
    Bull Soc Belge Ophtalmol; 2005 Feb; (297):69-77. PubMed ID: 16281735
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ, Jumper JM, Yang SS, Fu AD, Johnson RN, McDonald HR, Ai E.
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [Abstract] [Full Text] [Related]

  • 35. Objective evaluation of cataract progression associated with a high dose intravitreal triamcinolone injection.
    Chu YK, Chung EJ, Kwon OW, Lee JH, Koh HJ.
    Eye (Lond); 2008 Jul; 22(7):895-9. PubMed ID: 17435692
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
    Shimura M, Yasuda K, Shiono T.
    Ophthalmology; 2006 Mar; 113(3):381-7. PubMed ID: 16458970
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.